Global Trends in CD4 Count Measurement and Distribution at First Antiretroviral Treatment Initiation

Reneé de Waal; Kara Wools-Kaloustian; Ellen Brazier; Keri N. Althoff; Antoine Jaquet; Stephany N. Duda; Nagalingeswaran Kumarasamy; Theodora Savory; Helen Byakwaga; Gad Murenzi; Amy C. Justice; Didier Koumavi Ekouévi; Carina César; Mark KU Pasayan; Agness Thawani; Charles Kasozi; Pélagie Babakazo; Maile Karris; Eugène Messou; Claudia P. Cortés; Cordelia Kunzekwenyika; Jun Yong Choi; Noela Owarwo; Annabelle Niyongabo; Vincent C. Marconi; Oliver Ezechi; Jessica L. Castilho; Kathy Petoumenos; Leigh F. Johnson; Nathan Ford; Reshma Kassanjee

doi:10.1093/cid/ciae548

Abstract

This is the authors' abstract. We don't add key points for this paper.

CD4 measurement has declined sharply in recent years, especially in sub-Saharan Africa. Among those with a CD4 measurement, the prevalence of CD4 <200 remains concerningly high. Scaling up CD4 testing and securing adequate funding are urgent priorities.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Waal et al. (2024) studied this question.

synapsesocial.com/papers/69d812f15c3030ff03d19171 https://doi.org/10.1093/cid/ciae548

View Full Paper

Ask AI

Bookmark

Share

Global Trends in CD4 Count Measurement and Distribution at First Antiretroviral Treatment Initiation

Abstract

Ask about this paper

Discussion

Cite This Study

Global Trends in CD4 Count Measurement and Distribution at First Antiretroviral Treatment Initiation

Abstract

Ask about this paper

Discussion

Cite This Study

Keep reading

Keep reading